(Reuters) - Short-term, low-dose use of a popular group of ulcer drugs is unlikely to pose a risk of fractures, the U.S. Food and Drug Administration said on Wednesday.
(Reuters) - Short-term, low-dose use of a popular group of ulcer drugs is unlikely to pose a risk of fractures, the U.S. Food and Drug Administration said on Wednesday.
